Gebasaxturev
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Gebasaxturev, covering 2024-08-06 to 2024-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013) [Phase 1, Phase 2]